Evidence map›Paper›PMID 35345480›Full record

ArticleToxicon: X2022

Antifungal activity of

Umberto Zottich, Isadora Sousa de Oliveira, Isabela Gobbo Fereira, Felipe Augusto Cerni, Bordon Karla de Castro Figueiredo, Eliane Candiani Arantes, Valdirene Moreira Gomes, Germana Bueno Dias, Manuela Berto Pucca

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicon: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Umberto ZottichMedical School, Federal University of Roraima, Boa Vista, Roraima, Brazil.
Isadora Sousa de OliveiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Isabela Gobbo FereiraDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Felipe Augusto CerniHealth Sciences Postgraduate Program, Federal University of Roraima, Boa Vista, Brazil.
Bordon Karla de Castro FigueiredoDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Eliane Candiani ArantesDepartment of BioMolecular Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
Valdirene Moreira GomesCentro de Biociências e Biotecnologia, Universidade Estadual Do Norte Fluminense, 28013-602, Campos Dos Goytacazes, Rio de Janeiro, Brazil.
Germana Bueno DiasHealth Sciences Postgraduate Program, Federal University of Roraima, Boa Vista, Brazil.
Manuela Berto PuccaMedical School, Federal University of Roraima, Boa Vista, Roraima, Brazil.
Universidade de São Paulo · BRUniversidade Federal de Roraima · BRState University of Norte Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungal infections are becoming a serious problem of human diseases, being one of the most important fungal pathogens the yeast of the genus

Indexed as

AntifungalCandida albicansCandida parapsilosisRhopalurus crassicaudascorpion Toxin

Identifiers

PMID35345480
PMCPMC8956938
OpenAlexW4220862243

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.